Articles nAture methods | VOL.12 NO.9 | SEPTEMBER 2015 | 879 high-throughput rnA sequencing has accelerated discovery of the complex regulatory roles of small rnAs, but rnAs containing modified nucleosides may escape detection when those modifications interfere with reverse transcription during rnA-seq library preparation. here we describe AlkB-facilitated rnA methylation sequencing (Arm-seq), which uses pretreatment with Escherichia coli AlkB to demethylate N 1 -methyladenosine (m 1 A), N 3 -methylcytidine (m 3 c) and N 1 -methylguanosine (m 1 G), all commonly found in trnAs. comparative methylation analysis using Arm-seq provides the first detailed, transcriptome-scale map of these modifications and reveals an abundance of previously undetected, methylated small rnAs derived from trnAs. Arm-seq demonstrates that trnA fragments accurately recapitulate the m 1 A modification state for well-characterized yeast trnAs and generates new predictions for a large number of human trnAs, including trnA precursors and mitochondrial trnAs. thus, Arm-seq provides broad utility for identifying previously overlooked methyl-modified rnAs, can efficiently monitor methylation state and may reveal new roles for trnA fragments as biomarkers or signaling molecules.
high-throughput rnA sequencing has accelerated discovery of the complex regulatory roles of small rnAs, but rnAs containing modified nucleosides may escape detection when those modifications interfere with reverse transcription during rnA-seq library preparation. here we describe AlkB-facilitated rnA methylation sequencing (Arm-seq), which uses pretreatment with Escherichia coli AlkB to demethylate N 1 -methyladenosine (m 1 A), N 3 -methylcytidine (m 3 c) and N 1 -methylguanosine (m 1 G), all commonly found in trnAs. comparative methylation analysis using Arm-seq provides the first detailed, transcriptome-scale map of these modifications and reveals an abundance of previously undetected, methylated small rnAs derived from trnAs. Arm-seq demonstrates that trnA fragments accurately recapitulate the m 1 A modification state for well-characterized yeast trnAs and generates new predictions for a large number of human trnAs, including trnA precursors and mitochondrial trnAs. thus, Arm-seq provides broad utility for identifying previously overlooked methyl-modified rnAs, can efficiently monitor methylation state and may reveal new roles for trnA fragments as biomarkers or signaling molecules.
High-throughput RNA-sequencing has provided insight into the importance of small RNAs in a wide range of biological contexts. tRNAs are among the most abundant RNAs in all organisms, so it is perhaps unsurprising that tRNA fragments and half-molecules are often abundant constituents of small-RNA sequencing libraries [1] [2] [3] . There is increasing evidence that these tRNAderived RNAs can have important functions distinct from those of mature tRNAs [4] [5] [6] [7] [8] , including potential roles in disease 4,5,9 . However, tRNA fragments are likely to escape sequencing-based detection when they contain nucleoside modifications similar to those in mature tRNAs. Many tRNA modifications cause pauses or stops during reverse transcription 10 , a critical step in most RNA-seq protocols. These so-called hard-stop modifications, including m 1 A, m 1 G, N 2 ,N 2 -dimethylguanosine (m 2 2 G) and m 3 C, are more prevalent in tRNAs than in other classes of RNAs and likely play important roles in the biogenesis, stability and functional activities of tRNA fragments, much as they do for Arm-seq: AlkB-facilitated rnA methylation sequencing reveals a complex landscape of modified trnA fragments Aaron E Cozen 1 , Erin Quartley 2 , Andrew D Holmes 1 , Eva Hrabeta-Robinson 1 , Eric M Phizicky 2,3 & Todd M Lowe 1 mature tRNAs 11 . For example, specific modifications can target tRNAs for cleavage into half-molecules 12 , protect tRNAs from cleavage 13, 14 , or alter the interaction of tRNA fragments with proteins such as Dicer or Piwi 2,3,8 .
We developed ARM-seq to provide sensitive and specific detection of methyl-modified RNAs using RNA-seq. In ARM-seq, RNA is treated with a dealkylating enzyme, Escherichia coli AlkB, before reverse transcription in library preparation. Differential abundance analysis comparing treated to untreated samples efficiently identifies RNAs sequenced more frequently after demethylation. The known substrates of E. coli AlkB in RNA are m 1 A, documented in approximately half of all well-characterized tRNAs, and m 3 C, a less common modification documented primarily in tRNAs [15] [16] [17] . There is also evidence that E. coli AlkB can demethylate m 1 G, which is nearly as prevalent as m 1 A in tRNAs, although by a different mechanism 18 .
In our analyses of budding yeast (Saccharomyces cerevisiae) and human cell lines, ARM-seq greatly increased the abundance and diversity of reads for tRNA fragments. Furthermore, ARM-seq fragment analyses correctly predicted the identity and position of modified residues when compared to previous documentation 17 for corresponding mature tRNAs. This approach, corroborated by primer extension experiments, correctly predicted the m 1 A modification state for the complete set of known yeast tRNAs with 94% accuracy, including several for which modifications were verified to differ from previous studies. ARM-seq also provided compelling evidence for m 1 A modifications in a large proportion of human tRNAs for which modification patterns were unknown or not documented. Thus, ARM-seq facilitates sequencing of methyl-modified RNAs that otherwise escape detection in standard sequencing protocols, and it can be used to rapidly characterize methylation patterns across diverse transcriptomes.
results

Arm-seq enables detection of methylated trnA fragments
We first tested the ARM-seq methodology ( Fig. 1 and Supplementary Software) on S. cerevisiae, where tRNAs and their modifications 17 have been most extensively characterized. Initial experiments showed that demethylation conditions used for ARM-seq specifically removed m 1 A and m 3 C modifications from target RNAs (Supplementary Fig. 1 ). ARM-seq more than doubled the proportion of small-RNA sequencing reads from tRNA genes from 6.9% to 15.1% ( Fig. 2a and Supplementary  Table 1 ). These increases corresponded almost entirely to tRNA fragments rather than full-length mature tRNAs (Supplementary Table 2 ), indicating that a large proportion of tRNA fragments in yeast contain AlkB-sensitive modifications. In contrast, the share of reads mapping to other major classes of small RNAs diminished slightly ( Supplementary Table 1 ).
Arm-seq predicts the m 1 A modification state of mature trnAs
Next, we showed that ARM-seq abundance ratios (RNA-seq read counts from AlkB-treated versus untreated RNA) and read profiles detected known m 1 A tRNA modifications as effectively as traditional primer extension experiments. Thr-AGT tRNA, which is known to contain m1A at position 58 (m 1 A58), showed a 16-fold increase in normalized read count corresponding to fragments that include A58 ( Fig. 2b) . Primer extensions targeting mature Thr-AGT tRNA revealed a hard-stop band corresponding to m 1 A58 in an untreated sample, versus much lower band intensity in the corresponding AlkB-treated sample, consistent with demethylation of the expected m 1 A58 modification ( Fig. 2c) . By contrast, ARM-seq produced no significant effect for His-GTG ( Fig. 2b) , a true negative where an expected unmodified A58 was also confirmed by primer extension (Fig. 2c) . Similar comparisons confirmed ARMseq predictions for three isodecoder groups with no previous modification data (Leu-GAG, Arg-CCG and Gly-CCC) and one isodecoder group (Gln-TTG) for which A58 was previously documented as unmodified 7 but shown to be methylated by both ARM-seq and primer extension ( Fig. 2b,c) .
Because ARM-seq read profiles of tRNA fragments correctly predicted the m 1 A58 modification state for the mature tRNAs tested, we examined ARM-seq results for the complete set of yeast tRNAs. On the basis of our initial verified test data, we used a twofold increase in read abundance and a DEseq2 P value <0.01 (see Online Methods) as our threshold for identifying all significant ARM-seq responses.
ARM-seq correctly predicted the modification state for 22 of 26 yeast tRNAs with documented 17 m 1 A58 modifications ( Fig. 2d, Supplementary Figs. 2 and 3 and Supplementary  Table 2 ). Among the other four tRNAs, ARM-seq predicted unmodified A58 in two (Leu-TAA-1 and Lys-CTT-1), which were confirmed by primer extension ( Fig. 2d and Supplementary  Fig. 4 ). The last two tRNAs expected to contain m 1 A58 (Ile-TAT-1 and Val-CAC-1) showed visible increases in read count but were not quite significant by our cutoff criteria ( Fig. 2d and Supplementary Fig. 2b) .
Conversely, ARM-seq produced profiles consistent with unmodified A58 for 15 of 19 tRNAs in isodecoder groups expected to lack m 1 A58 ( Supplementary Fig. 2 ) and correctly identified three others (Gln-TTG isodecoders) for which unexpected m 1 A58 modifications were confirmed by primer extension ( Fig. 2b,c) . ARM-seq profiles for the last tRNA in this group, Ser-CGA, showed evidence for demethylation of both an expected m 3 C32 modification and an unexpected m 1 A58.
ARM-seq also predicted m 1 A58 modifications for five yeast tRNAs in isodecoder groups not represented in the Modomics database of RNA modifications and predicted unmodified A58 for three others, with primer extensions confirming m 1 A58 for Leu-GAG and unmodified A58 for Arg-CCG and Gly-CCC ( Fig. 2c,d and Supplementary Fig. 2d ). The final tRNA not represented in Modomics, Pro-AGG, showed evidence for partial AlkB sensitivity that was also confirmed by primer extension (Supplementary Fig. 4) .
In summary, for all yeast tRNAs where m 1 A58 modification state was either corroborated by documentation in Modomics or verified by primer extensions, ARM-seq correctly predicted 26 of 28 that contain m 1 A58 (93% sensitivity) and 18 of 19 that contain unmodified A58 (95% specificity), demonstrating a combined accuracy of 94% overall.
Arm-seq reveals methylated human trnA fragments
The tRNA repertoire in humans is substantially more complex. Of 414 unique human mature tRNA sequences identified by the program tRNAscan-SE 19, 20 , just 43 match entries in Modomics. ARM-seq demethylation increased the proportion of RNA-seq reads mapping to tRNAs from 2.9% to 10.1% in a B cell-derived cell line (GM12878) and from 3.9% to 13.2% in a B-cell lymphoma-derived cell line (GM05372), about 3.5-fold in each In ARM-seq, removal of m 1 A, m 3 C, or m 1 G modifications by AlkB treatment facilitates the production of full-length cDNAs from previously modified templates, producing a ratio of reads in treated versus untreated samples that can be used to identify methylated RNAs. Typical positions for m 1 A, m 3 C or m 1 G modifications are indicated in the schematic showing tRNA secondary structure in canonical cloverleaf form. npg case ( Supplementary Fig. 5 and Supplementary Table 1 ). These increases again corresponded to detection of modified tRNA fragments rather than of full-length mature tRNAs (Supplementary Table 3 ). The tRNA 3′ fragments detectable only with ARM-seq all included A58, positively predicting 15 of the 17 (88%) human isodecoder groups expected to contain m 1 A58 modifications ( Fig. 3a,b) . ARM-seq also correctly identified the only isodecoder group expected to contain unmodified A58 (Glu-CTC; Supplementary Fig. 6d ). Examining all isotypes, ARM-seq produced an unprecedented set of methylation predictions encompassing the full spectrum of human isodecoder groups ( Supplementary  Fig. 6a,b and Supplementary Data).
Arm-seq identifies methyl-modified pre-trnAs and mitochondrial trnAs
A subset of transcripts revealed by ARMseq in the human samples preferentially mapped to tRNA genes rather than mature tRNA transcripts because they included genomically encoded sequences found only in tRNA precursors ( Fig. 3c and Supplementary Figs. 7-11 ). Most tRNA base modifications are thought to occur after cleavage of 5′ leader and 3′ trailer sequences from tRNA-precursor transcripts 21 . Evidence demonstrating m 1 A58 modification of initiator methionine pre-tRNAs in yeast and exogenous pre-tRNAs in Xenopus laevis oocytes established a limited precedent for this particular modification at an earlier stage in pre-tRNA processing 22, 23 , but direct evidence for early m 1 A58 modification has been lacking for most organisms, including humans. Surprisingly, ARM-seq identified modified precursors for most human acceptor types ( Supplementary Fig. 12 and Supplementary Table 3 ), even though pre-tRNAs are less abundant and more challenging to detect than mature tRNAs. (b) ARM-seq read profiles for individual tRNAs show increases in 3′-fragment reads relative to untreated samples (for example, Thr-AGT) that predict the presence of m 1 A58 in some tRNAs (indicated by *). By contrast, ARM-seq profiles for other tRNAs show comparable or diminished 3′ reads (for example Arg-CCG), predicting unmodified A58 in these tRNAs. x axes in a and b display canonical tRNA positions, excluding extended type II variable loops (ac, anticodon). (c) Primer extensions targeting six corresponding mature tRNAs demonstrate that these ARM-seq results reflect the modification patterns of mature tRNAs, confirming the A58 modification state documented in Modomics (for tRNAs indicated in brown in b and d), and providing new information on the m 1 A58 modification state (for tRNAs in gray in b and d).
Table notation (+++, ++ and −) summarizes relative magnitude of AlkB effect in primer extension or ARM-seq. (d) Significant ARM-seq response (for example Arg-ACG), or lack of response (for example His-GTG) are displayed in context of all tRNAs in yeast. tRNAs for which ARM-seq predictions were verified by primer extension are indicated in orange. P-value < 0.01 indicated by *.
npg
Overall, pre-tRNAs in 33 different isodecoder families from 86 different human tRNA gene loci showed significant ARMseq responses in at least one of the two cell lines. A large subset of these, 38 loci, showed significant ARM-seq responses in both cell lines. Primer extensions confirmed an AlkB-sensitive block corresponding to m 1 A58 in a human Leu-CAA pre-tRNA ( Supplementary Fig. 8b) . Thus, ARM-seq provides the first evidence that many human pre-tRNAs are m 1 A58 modified before 5′ leader and 3′ trailer removal, suggesting this pattern occurs broadly among eukaryotes.
ARM-seq also efficiently revealed modifications in human mitochondrial tRNAs. Of 22 human mitochondrial tRNAs, npg 8 are currently documented 17 , showing m 1 A9, m 1 G9, m 1 G37 and m 1 A58 as the most frequent hard-stop modifications. More extensively characterized bovine mitochondrial tRNAs show at least one difference in modification relative to humans for seven of these (all except initiator methionine), underscoring the need for specific characterization of human mitochondrial tRNAs 17, 24 . ARM-seq produced significant increases in read count, identifying modified RNAs derived from 12 mitochondrial tRNAs in GM12878 cells, 8 of which also showed significant responses in the GM05372 samples ( Fig. 3d, Supplementary Fig. 7 and Supplementary Table 3 ). In contrast to human cytosolic tRNAs, for which ARM-seq responses were attributable exclusively to m 1 A58 modification state, ARM-seq profiles for human mitochondrial tRNAs provided evidence for m 1 A9 (in mito-Asp-GTC, mito-Lys-TTT and mito-Pro-TGG), m 1 G9 (in mito-Ile-GAT and mito-Tyr-GTA), m 1 G37 (in mito-Leu-TAG and mito-Pro-TGG) and m 1 A58 (in mito-Leu-TAA). Primer extensions confirmed AlkB-mediated demethylation of m 1 A9 for mito-Pro-TGG, m 1 G9 in mito-Ile-GAT and a previously undocumented m 1 G9 in mito-Tyr-GTA (Supplementary Fig. 8b) .
discussion
ARM-seq results show that a large fraction of small RNAs in both budding yeast and human cells contain base modifications that reflect their biogenesis from modified tRNAs. Recently developed protocols provide tools to profile N 6 -methyladenosine (m 6 A)-, pseudouridine-and N 5 -methylcytidine (m 5 C)-modified RNAs using high-throughput sequencing, revealing new and unexpected targets for these modifications [25] [26] [27] [28] [29] . ARM-seq adds the capacity to profile m 1 A-, m 3 C-or m 1 G-modified RNAs, which are otherwise recalcitrant to sequencing, revealing a complex landscape of modified tRNA fragments in two evolutionarily divergent organisms. Sequences of the most abundant of these are listed (Supplementary Table 4) , with all 1,634 read profiles available for individual examination (Supplementary Data) .
The power of ARM-seq as a screen for m 1 A-, m 3 C-and m 1 G-modified RNAs can be maximized by leveraging prior knowledge from databases such as Modomics and complementary experimental approaches such as primer extension and mass spectrometry to identify the specific nature and location of modified residues. ARM-seq demonstrates remarkable accuracy in predicting previously documented tRNA modification patterns and perfect agreement with corresponding primer extensions for unexpected modifications. Furthermore, results showing that many human pre-tRNAs are modified by m 1 A demonstrate that ARM-seq can dissect complex sequential steps of RNA processing and modification, with potential application for identifying modification-based regulatory checkpoints. ARM-seq profiles revealing m 1 A-and m 1 G-modified mitochondrial tRNAs also suggest uses investigating mitochondrial genetic diseases, in which defects in mitochondrial tRNAs often play central roles 30 .
Our results, including untreated samples, do not show the same evidence for nucleotide misincorporation at expected hardstop modifications that has been reported in other studies [31] [32] [33] [34] . Although signature mismatches in sequencing data can identify modified or edited residues, ARM-seq is almost certainly more sensitive and quantitative for detection of modified RNAs because it does not depend on low-frequency reverse-transcription errors that are poorly understood and possibly context dependent.
ARM-seq should facilitate the study of tRNA processing and modification in a wide range of biological settings, including investigation of new model organisms as well as comparative analyses of different developmental stages, tissue types and disease states. Such studies may illuminate new facets of tRNA biology-for example, by revealing tissue-specific functions for distinct tRNA variants 35 -or important regulatory functions for new tRNA fragments 5 . These typically overlooked small RNAs outnumbered microRNAs by fourfold or more ( Supplementary  Fig. 5 ), which underscores their potential involvement in cellular signaling and regulation as well as in disease states including neurodegeneration, cancer and viral infections 4, 5, 9 . Whether base modifications play central roles in these activities, and whether modifications have obscured detection of members of other classes of RNAs, such as mRNAs or long noncoding RNAs, is among the many potential lines of research now accessible with this methodology. Growth of yeast cells and RNA isolation. S. cerevisiae cells (strain BY4741) were grown in liquid YPD medium at 30 °C to OD 600 = 1-2, and 300 OD cells were harvested and quick frozen at −80 °C. Bulk RNA was prepared from cell pellets using hot phenol 36 , typically yielding 2 mg RNA. Bulk RNA from three independently inoculated cultures was processed separately in subsequent treatments.
Growth of human cell lines and RNA isolation. Cell pellets of human B lymphocyte-derived cell lines GM05372 and GM12878
were purchased from Coriell Institute and shipped frozen after a PBS wash. Cell lines were authenticated using microsatellite analysis and verified as free of mycoplasma infection by Coriell Institute. Upon arrival, cells were immediately placed at −80 °C for storage before RNA extraction. Isolation of total RNA from 10 8 human cells was performed using Direct-Zol RNA MiniPrep Kit (Zymo Research) with TRI Reagent (Molecular Research Center, Inc.), typically yielding 400-450 µg of total RNA. Total RNA samples from each of the two human cell lines were then split into three technical replicates for subsequent treatments. Sample size (n = 3) was selected to demonstrate the utility of the protocol at a level of replication achievable by most researchers.
Treatment of RNA with AlkB. AlkB treatment of RNA was performed in 200-µl reaction mixtures containing 50 mM HEPES KOH, pH 8, 75 µM ferrous ammonium sulfate, pH 5, 1 mM α-ketoglutarate, 2 mM sodium ascorbate, 50 µg/ml BSA, 50 µg AlkB and 50 µg bulk RNA at 37 °C for 100 min. AlkB reaction buffer was prepared fresh before each use. Reactions were stopped by addition of 200 µl buffer containing 11 mM EDTA and 200 mM ammonium acetate, followed by phenol extraction, ethanol precipitation and resuspension of the washed pellet in water. Control reactions for untreated samples were performed similarly, using AlkB storage buffer instead of AlkB. mapping scores to tRNA gene loci (which represent unprocessed pre-tRNA transcripts) and predicted mature tRNA sequences were mapped exclusively to mature tRNAs. Thus, reads with equivalent mapping scores to multiple gene loci (encoding tRNAs that are identical after maturation) were mapped instead to a single mature tRNA sequence. In addition, reads mapped by this procedure to tRNA gene loci all contain features of tRNA precursors that are not found in mature tRNAs (for example, intronic sequences, 3′ trailers or 5′ leaders). These pre-tRNA features often distinguish one tRNA gene locus from another even when the mature tRNA encoded is identical. Plots of read coverage profiles for tRNAs were produced using read counts that were normalized according to size factors calculated from DESeq2 analyses (see below).
Differential expression analysis.
Read counts were tabulated for all reads and assigned to mature tRNAs or genomic features where mapping produced at least 10 nt of sequence overlap. Nonoverlapping RNA sequences mapped to the same annotated genomic features were labeled and counted separately (for example, nonoverlapping RNAs mapped to a genomic feature annotated as HERVH-int were labeled HERVH-int.1, HERVHint.2, …). Read counts for all features that exceeded a minimum threshold of 20 reads were used as input to the DESeq2 R package with default parameters 39 . DESeq2 takes into account variability between replicates and normalizes read counts to account for differences in sequencing depth between samples, reporting ARM-seq fold changes relative to untreated samples along with associated P values that are adjusted for multiple-hypothesis testing. We used a twofold increase in read abundance with a DEseq2 P value of <0.01 as our threshold for identifying all significant ARM-seq responses. A doubling of read counts in ARM-seq versus untreated samples indicates the presence of AlkB-sensitive modifications in at least half of the detected RNA molecules derived from a given tRNA, whereas larger increases indicate an even greater proportion of modified molecules. With the exception of Supplementary Table 1 , which presents raw read counts and a proportional breakdown of read mappings by RNA class that is unaffected by normalization, all read counts reported in results and figures reflect normalization using DESeq2 size factors.
New tRNA naming convention. tRNA transcripts and individual gene loci are labeled using a new systematic naming convention that is designed to be more stable and informative (T.M.L. and P. Chan, unpublished data). The new tRNA naming convention echoes the systematic naming adopted for microRNAs in miRBase 40 . In brief, each unique mature tRNA transcript is named by isotype and codon (i.e., isodecoder), numbered in ascending order (for example, tRNA-Ala-AGC-1, tRNA-Ala-AGC-2, etc.), from most canonical to least canonical ('canonical' is objectively defined by the bit score given to each tRNA by tRNAscan-SE using the default general tRNA model 19 ). As with microRNAs, there are often multiple genome loci encoding identical mature tRNAs, so a secondary index number is assigned to denote specific tRNA gene loci (i.e., tRNA-Ala-AGC-1-1, tRNA-Ala-AGC-1-2, tRNA-Ala-AGC-1-3 describe different gene loci but produce identical mature tRNA transcripts). Thus, labels for mature tRNA transcripts include only the first index number, which refers to the specific unique tRNA (for example, tRNA-Ala-AGC-2), whereas labels for tRNA genes also include a second index, which refers to the locus number (i.e., tRNA-Ala-AGC-2-1). The new naming convention has been applied to all tRNAs in the Genomic tRNA Database 20 and has been adopted by the HUGO Gene Nomenclature Committee and by RNAcentral 41 . For convenience in cross-referencing, Supplementary Tables 1 and 2 also include legacy labels from the genomic tRNA database, where tRNA genes were labeled by chromosome number and order of occurrence 20 . By this new naming convention, we count 414 possible unique mature tRNAs in the GRCh37/hg19 assembly of the human genome (not including the ten tRNA predictions with undetermined anticodons).
Correspondence to modifications annotated in Modomics.
Predicted mature tRNA sequences were compared to those from the Modomics database (downloaded January 2015) to annotate modifications. tRNAs were labeled with annotated modifications from Modomics when these contained matching anticodons and the sequence of originating (unmodified) bases in Modomics matched those of the genomically encoded tRNAs with three or fewer nucleotide mismatches. tRNAs that did not match Modomics tRNA sequences using these criteria were labeled as "not documented."
Code availability. The software pipeline developed for this study includes components for trimming of raw sequencing reads, merging of paired-end reads, read mapping of small RNAs (including pre-tRNAs and mature tRNAs), abundance estimation and differential expression analysis (current version available at http://lowelab.ucsc.edu/software/).
